XIAO; Qitao
Patent Applications and Registrations
Patent applications and USPTO patent grants for XIAO; Qitao.The latest application filed is for "heterocyclic wdr5 inhibitors as anti-cancer compounds".
- XIAO; Qitao - Shanghai CN
| Patent | Date |
|---|---|
| Heterocyclic Wdr5 Inhibitors As Anti-cancer Compounds App 20220289732 - FANG; Lichao ; et al. | 2022-09-15 |
| Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents Grant 11,420,970 - Deng , et al. August 23, 2 | 2022-08-23 |
| Substituted 5-cyanoindole compounds and uses thereof Grant 10,604,502 - Du-Cuny , et al. | 2020-03-31 |
| Cyano-substituted indoles as LSD1 inhibitors Grant 10,590,079 - Du-Cuny , et al. | 2020-03-17 |
| Immune Effector Cell Therapies With Enhanced Efficacy App 20190298715 - Motz; Gregory ; et al. | 2019-10-03 |
| Cyano-substituted Indole Compounds And Uses Thereof As Lsd1 Inhibitors App 20190092724 - DU-CUNY; Lei ; et al. | 2019-03-28 |
| Substituted 5-cyanoindole Compounds And Uses Thereof App 20190023684 - DU-CUNY; Lei ; et al. | 2019-01-24 |
| Immune Effector Cell Therapies With Enhanced Efficacy App 20190000880 - Motz; Gregory ; et al. | 2019-01-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 